GSK will pay Scynexis $22 million to resolve a disagreement between the two companies over Scynexis' phase three study of a treatment for invasive candidiasis, a fungal infection. Scynexis will end ...
WRIC Richmond on MSN
7 risk factors of deadly fungus infections identified, new Candida auris research finds
Researchers are getting a better idea of what leads to clinical cases of Candida auris, a dangerous and drug-resistant fungus that has been rapidly multiplying.
Everyday Health on MSN
Foods to Avoid When You Have Oral Thrush
Learn about foods to avoid with thrush in your mouth, such as sugar and yeast. Discover how dietary and lifestyle changes can alleviate symptoms based on expert guidelines.
In recent days, the emergence of a Candida auris outbreak at Ling Shing Hospital has raised significant health concerns. This fungal infection, known for its resistance to treatment and ability to ...
Many yeast infections clear up in about a week on their own, but more serious infections can last longer and require ...
In a concerning development, Ling Shu Hospital has reported an outbreak of Candida auris, a multidrug-resistant fungus, affecting five male patients in its internal medicine and geriatric wards. This ...
SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive ...
Baby yeast infections are common and can appear as a bright, red rash with pimple-like spots or as a thick white coating on ...
A new report from the Centers for Disease Control and Prevention on the deadly drug-resistant bacteria NDM-CRE found a 70% ...
Combination therapies such as clindamycin and rifampin, Mayo said, are the most heavily researched combination therapy for HS. Triple therapies that include rifampin also consist of moxifloxacin and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results